Last update 08 May 2025

Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Influenza, Human
Originator Organization
Resilience Government Services, Inc.Resilience Government Services, Inc.
Active Organization-
Inactive Organization
Resilience Government Services, Inc.Resilience Government Services, Inc.
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)
NCT01320696
/ CompletedPhase 1/2
A Randomized, Double Blind, Multi-center, Phase 1/2 Study to Assess Safety and Immunogenicity of Five Dose Levels of a Reverse Genetic (RG) Reassortant H9N2 Pandemic Influenza Vaccine in Healthy Subjects Aged 18 to 49 Years
100 Clinical Results associated with Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)
Login to view more data
100 Translational Medicine associated with Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)
Login to view more data
100 Patents (Medical) associated with Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)
Login to view more data
100 Deals associated with Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine(Ology Bioservices)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 2
United States
Resilience Government Services, Inc.Resilience Government Services, Inc.
01 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free